Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

In Vivo Cross-sectional Imaging of a Degrading Dexamethasone Intravitreal Implant That Became Attached to the Macula

In Vivo Cross-sectional Imaging of a Degrading Dexamethasone Intravitreal Implant That Became... Letters 3. Kahook MY. Bleb morphology and vascularity after trabeculectomy with vasoproliferative wound healing can affect bleb survival. Al- intravitreal ranibizumab: a pilot study. Am J Ophthalmol. 2010;150(3):399-403.e1. thoughreportshavefocusedontheuseofsubconjunctivalorsub- 4. Ozgonul C, Mumcuoglu T, Gunal A. The effect of bevacizumab on wound Tenon injection of anti-VEGF agents in conjunction with trab- healing modulation in an experimental trabeculectomy model. Curr Eye Res. eculectomy, the cumulative effect of repeated intravitreous 2014;39(5):451-459. 2,3 injections on wound healing is likely similar. Furthermore, the 5. Guerriero E, Yu JY, Kahook MY, SundarRaj N, Schuman JS, Noecker RJ. wound-modulating effects of anti-VEGF agents may be dose de- Morphologic evaluation of bevacizumab (Avastin) treated corneal stromal fibroblasts [ARVO e-abstract 1642]. Invest Ophthalmol Vis Sci. 2006;47:1642. pendent: a higher dosage or more frequent treatments may have 4,5 agreatereffect. Anti–vascularendothelialgrowthfactoragents, 6. Wilcox MJ, Minckler DS, Ogden TE. Pathophysiology of artificial aqueous drainage in primate eyes with Molteno implants. J Glaucoma. 1994;3(2):140-151. especiallyifusedintheperioperativeperiodaftertrabeculectomy, 1,2 result in blebs that are thinner and less vascular. The proposed benefit of anti-VEGF injections in trabecu- In Vivo Cross-sectional Imaging of a Degrading lectomy may result in complications associated with Dexamethasone Intravitreal Implant That Became reduced wound healing with GDI surgery, as we have http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Ophthalmology American Medical Association

In Vivo Cross-sectional Imaging of a Degrading Dexamethasone Intravitreal Implant That Became Attached to the Macula

Loading next page...
 
/lp/american-medical-association/in-vivo-cross-sectional-imaging-of-a-degrading-dexamethasone-uhpnvkN38v
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6165
eISSN
2168-6173
DOI
10.1001/jamaophthalmol.2014.5153
pmid
25521427
Publisher site
See Article on Publisher Site

Abstract

Letters 3. Kahook MY. Bleb morphology and vascularity after trabeculectomy with vasoproliferative wound healing can affect bleb survival. Al- intravitreal ranibizumab: a pilot study. Am J Ophthalmol. 2010;150(3):399-403.e1. thoughreportshavefocusedontheuseofsubconjunctivalorsub- 4. Ozgonul C, Mumcuoglu T, Gunal A. The effect of bevacizumab on wound Tenon injection of anti-VEGF agents in conjunction with trab- healing modulation in an experimental trabeculectomy model. Curr Eye Res. eculectomy, the cumulative effect of repeated intravitreous 2014;39(5):451-459. 2,3 injections on wound healing is likely similar. Furthermore, the 5. Guerriero E, Yu JY, Kahook MY, SundarRaj N, Schuman JS, Noecker RJ. wound-modulating effects of anti-VEGF agents may be dose de- Morphologic evaluation of bevacizumab (Avastin) treated corneal stromal fibroblasts [ARVO e-abstract 1642]. Invest Ophthalmol Vis Sci. 2006;47:1642. pendent: a higher dosage or more frequent treatments may have 4,5 agreatereffect. Anti–vascularendothelialgrowthfactoragents, 6. Wilcox MJ, Minckler DS, Ogden TE. Pathophysiology of artificial aqueous drainage in primate eyes with Molteno implants. J Glaucoma. 1994;3(2):140-151. especiallyifusedintheperioperativeperiodaftertrabeculectomy, 1,2 result in blebs that are thinner and less vascular. The proposed benefit of anti-VEGF injections in trabecu- In Vivo Cross-sectional Imaging of a Degrading lectomy may result in complications associated with Dexamethasone Intravitreal Implant That Became reduced wound healing with GDI surgery, as we have

Journal

JAMA OphthalmologyAmerican Medical Association

Published: Mar 1, 2015

References